Literature DB >> 3120770

Unfolding and refolding of a type kappa immunoglobulin light chain and its variable and constant fragments.

M Tsunenaga1, Y Goto, Y Kawata, K Hamaguchi.   

Abstract

By limited proteolysis of a type kappa immunoglobulin light chain (Oku) with clostripain, both the VL and CL fragments were obtained with a high yield. The unfolding and refolding by guanidine hydrochloride of light chain Oku and its VL and CL fragments were studied at pH 7.5 and 25 degrees C with circular dichroism and tryptophyl fluorescence. The concentration of guanidine hydrochloride at the midpoint of the unfolding curve was 1.2 M for the VL fragment and 0.9 M for the CL fragment. As in the case of the CL fragment of light chain Nag (type lambda) [Goto, Y., & Hamaguchi, K. (1982) J. Mol. Biol. 156, 891-910], the unfolding and refolding kinetics of the CL fragment could be explained in principle on the basis of the three-species mechanism U1 in equilibrium U2 in equilibrium N, where N is native protein and U1 and U2 are the slow-folding and fast-folding species, respectively, of unfolded protein. The unfolding and refolding kinetics of the VL(Oku) fragment were described by a single exponential term. Double-jump experiments, however, showed that two forms of the unfolding molecule exist. The equilibrium and kinetics of unfolding of light chain Oku were explained by the sum of those of the VL and CL fragments. On the other hand, the refolding kinetics of light chain Oku were greatly different from the sum of those of the VL and CL fragments.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120770     DOI: 10.1021/bi00393a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Thermodynamic stability of a kappaI immunoglobulin light chain: relevance to multiple myeloma.

Authors:  Connie M Chung; Jenny D Chiu; Lawreen H Connors; Olga Gursky; Amareth Lim; Andrew B Dykstra; Juris Liepnieks; Merrill D Benson; Catherine E Costello; Martha Skinner; Mary T Walsh
Journal:  Biophys J       Date:  2005-03-25       Impact factor: 4.033

2.  Dominant negative inhibition by fragments of a monomeric enzyme.

Authors:  J E Michaels; P Schimmel; K Shiba; W T Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Physical and epitope analysis of a recombinant human T-cell receptor V alpha/V beta construct support the similarity to immunoglobulin.

Authors:  D F Lake; S Helgerson; W J Landsperger; J J Marchalonis
Journal:  J Protein Chem       Date:  1997-05

4.  A role for destabilizing amino acid replacements in light-chain amyloidosis.

Authors:  M R Hurle; L R Helms; L Li; W Chan; R Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  Destabilizing loop swaps in the CDRs of an immunoglobulin VL domain.

Authors:  L R Helms; R Wetzel
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

6.  Characterization of a quaternary-structured folding intermediate of an antibody Fab-fragment.

Authors:  H Lilie; R Jaenicke; J Buchner
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

7.  Conformation and stability of thiol-modified bovine beta-lactoglobulin.

Authors:  K Sakai; K Sakurai; M Sakai; M Hoshino; Y Goto
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

8.  Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.

Authors:  Kathrin Andrich; Ute Hegenbart; Christoph Kimmich; Niraja Kedia; H Robert Bergen; Stefan Schönland; Erich Wanker; Jan Bieschke
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

9.  Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.

Authors:  P H Tan; B M Sandmaier; P S Stayton
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

10.  Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation.

Authors:  G Esposito; R Michelutti; G Verdone; P Viglino; H Hernández; C V Robinson; A Amoresano; F Dal Piaz; M Monti; P Pucci; P Mangione; M Stoppini; G Merlini; G Ferri; V Bellotti
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.